argenx SE (ARGX)

Healthcare · Biotechnology · NASDAQ

argenx SE (ARGX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $59.94B, a trailing price-to-earnings ratio of 37.0 and a free-cash-flow yield of 0.9%. Over the most recent reported fiscal year, revenue grew 89.6%.

Market cap	$59.94B
Trailing P/E	37.0
FCF yield	0.9%
Revenue growth (YoY)	+89.6%
EPS growth (YoY)	+1159.3%
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ARGX data on Nama Insights →

Recent Congressional trades

argenx SE trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Daniel Goldman	House	Sell	$1,001 - $15,000	Aug 13, 2023